Good post.
But does ACW have the skills and motivation to suddenly pivot from being a cognitive enhancement company to being a depressive disorders company?
Anyway, we must "follow the science".
Ann: ACW XanaCIDD phase 2a trial topline results, page-104
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $78.63M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.7¢ | $567.1K | 19.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2204520 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 555543 | 4 |
View Market Depth
| Last trade - 12.59pm 13/08/2024 (20 minute delay) ? |
| ACW (ASX) Chart |